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Introduction
============

Researchers must cross a multitude of barriers to document a sufficiently large cohort to study rare diseases and procedures \[[@REF1]\]. National databases allow expedited investigation of widespread trends and demographics for clinical interpretation \[[@REF1]-[@REF4]\]. Retrospective analysis of focused cohorts provides clinicians with opportunities to understand their patient population comprehensively and implement care delivery strategies to improve outcomes. This is a crucial step in preventing medical errors and improving the quality of care \[[@REF1],[@REF5]\]. As database studies gain traction among researchers; it is essential to ensure external validity by understanding key characteristics and composition of the databases, which is made difficult due to limited granularity of clinical circumstances, before confidently generalizing the results to the clinical population \[[@REF6]\].

One such focused population that remains difficult to be studied prospectively is the elderly who undergo spine procedures. Wary surgeons refrain from operating on this population due to the prevalence of comorbidities and frailty \[[@REF7],[@REF8]\]. However, certain advances, including minimally invasive surgery and enhanced recovery after surgery (ERAS), have drastically improved the procedural outcomes. A possible solution is to retrospectively extract outcomes from databases to assess the viability of spine surgery in the elderly population. The present study reports the differences in three commonly used databases, MarketScan, National Inpatient Sample (NIS), and National Surgical Quality Improvement Program (NSQIP) in regards to patient demographics, complications, and outcomes following spine surgery in octogenarians and nonagenarians. 

Materials and methods
=====================

Data sources

The Truven Health Analytics MarketScan® claims database collects participant information from Commercial Claims and Encounters, Medicare Supplemental and Coordination of Benefits and Medicaid databases. Insurance enrollment, inpatient and outpatient utility, and claims and costs are provided and organized based on 150 payers in the US from employer-based plans \[[@REF9]\]. A neurology/neurosurgery custom-dataset obtained from MarketScan spanning from 2000-2012 was used. Medicare in MarketScan is Medicare Supplemental (also called Medigap). These patients are those on Medicare who can afford to take supplemental insurance to cover some things that Medicare doesn\'t cover. 

The Healthcare Costs and Utilization Project (HCUP) NIS is the largest all-payer inpatient database that collates discharge patient information on all inpatient admissions in non-federal US hospitals. A stratified random sampling technique of the hospitals and patients produces a representative 20% subsample, which can be generalized to the American medical community \[[@REF10]\]. The Elixhauser comorbidity data was implemented to NIS in 1998, which allows for calculating risk adjustments through the database \[[@REF11]\]. We extracted a custom dataset spanning from 2000 to 2012 \[[@REF10]\]. The NIS data for this study was adapted from Drazin et al. with permission \[[@REF12]\]. 

National Surgical Quality Improvement Program (NSQIP) is a well-recognized nationally validated outcome-based database introduced by the American College of Surgeons (ACS) to improve the quality of surgical care. Data is extracted using the International Classification of Diseases (ICD) 9/10 and Current Procedural Terminology (CPT) codes using this database and include comorbidities and postoperative outcomes. 

Data extraction

The study population was composed of a retrospective cohort study of patients undergoing spine surgery procedures for spinal stenosis in the Truven Health Analytics MarketScan® database, NIS database, and NSQIP database from 2006-2016. Patient extraction was performed using the International Classification of Diseases, 9th edition (ICD-9) coding system (for all databases), and the Current Procedural Terminology, 4th edition (CPT-4) (for MarketScan only). MarketScan is a longitudinal database. For this study, the first occurring hospitalization, satisfying the extraction conditions, was used for patient characteristics and most outcomes. Patient baseline characteristics included: age, gender, comorbid status, insurance type, and primary procedure. Outcome measures included: in-hospital complication and mortality risks, length of stay (LOS), and stratified in-hospital complication risks. Multivariable analysis assessed the association of baseline and patient characteristics with perioperative complications.

Data was queried to identify patients between the ages of 80-100 years who underwent spinal decompression (ICD-9 codes: 03.0, 03.09), discectomy (ICD-9 codes: 80.50, 80.51), or spinal fusion (ICD-9 codes: 81.0, 81.00, 81.01, 81.02, 81.03, 81.04, 81.05, 81.06, 81.07, 81.08). Primary diagnoses included spinal stenosis (ICD-9 codes: 723.0, 724.0, 724.00, 724.01, 724.02, 724.09), claudication (ICD-9 codes: 724.03), disc herniation (ICD-9 codes: 722.0, 722.10, 722.11), and disc protrusion (ICD-9 codes: 722.30, 722.31, 722.32, 722.51, 722.52, 722.71, 722.72, 722.73). Supplemental tables summarize ICD-9/10 and CPT codes used to extract data from these databases (Appendices). Patients younger than age 80 years, older than 100, and those undergoing vertebroplasty and kyphoplasty (augmentation procedures) were excluded.

Statistical analysis

Patient characteristics were summarized using means and standard deviation (for continuous variables) and counts and percentage (for categorical variables). Differences were considered significant if p\<0.0001. Each outcome (mortality, complications, and length of stay), within each database, was analyzed in a multivariable analysis including four variables (age at diagnosis, gender, comorbid state, and procedural type). Results were presented in terms of odds ratio (OR) or relative risk (RR) with associated 95% confidence interval.

Results
=======

A total of 63,641 octogenarians and nonagenarians who underwent spinal decompression, discectomy, or fusion surgery for spinal stenosis were identified from all the databases. The baseline patient characteristics and procedure outcomes were compared between the 15,105 MarketScan, 40,854 NIS, and 7682 NSQIP patients. Calculated odds-ratio of experiencing a perioperative complication during index hospitalization is presented in Table [1](#TAB1){ref-type="table"}.

###### Adjusted Odds Ratio (OR) of Complications at Index Hospitalization and 30 Days After Admission

  ---------------------------------- ------------------------- ----------------------------- --------------------------- ----------------------------------------------- -------------------------- -----------------------------------------------
                                                               Index Hospital Complication                               30-day from admission Complication                                         
                                                               MarketScan                    National Inpatient Sample   National Surgical Quality Improvement Program   MarketScan                 National Surgical Quality Improvement Program
  Variable                                                                                                                                                                                          
  Age, 1 year increase               1.05 (1.03, 1.08)         1.05 (1.04, 1.07)             1.01 (0.94, 1.09)           1.04 (1.02, 1.06)                               1.02 (0.98, 1.07)          
  Gender (ref: male)                                                                                                                                                                                
                                     Female                    0.83 (0.73, 0.95)             0.73 (0.67, 0.8)            0.78 (0.53, 1.13)                               0.81 (0.73, 0.89)          0.75 (0.61, 0.93)
  Comorbidities group (ref: 0)                                                                                                                                                                      
                                     1                         0.91 (0.78, 1.06)             1.07 (0.94, 1.22)           1.15 (0.49, 2.71)                               0.98 (0.88, 1.1)           1.06 (0.67, 1.67)
                                     2                         1.15 (0.96, 1.37)             1.54 (1.35, 1.76)           2.16 (0.96, 4.87)                               1.21 (1.06, 1.39)          1.63 (1.05, 2.52)
                                     3-8                       1.29 (0.96, 1.74)             2.52 (2.16, 2.94)           2.45 (1.07, 5.61)                               1.47 (1.18, 1.83)          2.69 (1.74, 4.17)
  Diagnosis (ref: Spinal stenosis)                                                                                                                                                                  
                                     Disc herniation           0.85 (0.68, 1.07)             0.88 (0.76, 1.03)           0.57 (0.26, 1.22)                               0.9 (0.76, 1.06)           0.82 (0.57, 1.18)
                                     Disc protrusion           1.2 (1.01, 1.43)              1.2 (1.07, 1.35)            1.4 (0.84, 2.34)                                1.16 (1.02, 1.33)          0.87 (0.61, 1.23)
                                     Degeneration              0.9 (0.74, 1.11)              0.86 (0.75, 0.99)           0.87 (0.49, 1.56)                               1.01 (0.87, 1.17)          1.06 (0.78, 1.45)
  Procedure (ref: fusion)                                                                                                                                                                           
                                     Decompression             0.58 (0.5, 0.68)              0.6 (0.55, 0.67)            0.48 (0.32, 0.72)                               0.64 (0.57, 0.71)          0.55 (0.43, 0.69)
                                     Discectomy                0.61 (0.47, 0.81)             0.69 (0.59, 0.8)            0.45 (0.25, 0.82)                               0.71 (0.59, 0.87)          0.54 (0.39, 0.74)
  ---------------------------------- ------------------------- ----------------------------- --------------------------- ----------------------------------------------- -------------------------- -----------------------------------------------

Demographics and patient characteristics

The median age was 82 years (IQR: 81-85) in all the databases. MarketScan and NIS databases found females to have undergone frequent spine surgeries compared to males (53% vs. 54%, respectively), whereas the NSQIP database showed an equal proportion of males and females undergoing surgeries, Table [2](#TAB2){ref-type="table"}. A majority of patients in both MarketScan and NIS were insured by Medicare (97% vs. 94%). Medicaid was more commonly reported with MarketScan enrollees compared to NIS enrollees (3.1% vs. 0.27%). Because NIS accumulates data on all payers, it has the ability to report commercial/private (4.7%) and other methods of payments (1.08%). Patients in MarketScan had lower comorbidity scores (comorbidity: 0-2) compared to those in NIS and NSQIP databases. Patients with 3+ comorbidities constituted 4% in MarketScan, 9% in NIS and 22% in NSQIP databases. Hypertension was the most common comorbidity, with a median of one comorbidity across the MarketScan and NIS databases (NSQIP: median, 2 comorbidities).

###### Patient Characteristics (2006-2016)

  ------------------------------ -------------------- --------------- --------------------------- -----------------------------------------------
                                                      MarketScan      National Inpatient Sample   National Surgical Quality Improvement Program
  Variable                       N=15105              N=40854         N=7682                      
  Age                                                                                             
                                 Mean (SD)            83.1 (2.8)      83.1 (2.8)                  82.9 (2.5)
                                 Median (IQR)         82 (81, 85)     82 (81, 85)                 82 (81, 85)
                                 Range (min-max)      80-103          80-110                      80-89
  Gender, n (%)                                                                                   
                                 Female               7974 (52.79%)   22224 (54.43%)              3835 (49.93%)
  Race, n (%)                                                                                     
                                 White                                31396 (76.85%)              6600 (85.92%)
                                 Black                                1022 (2.5%)                 236 (3.07%)
                                 Other/unknown                        8436 (20.65%)               846 (11.01%)
  Type of Insurance, n (%)                                                                        
                                 Commercial/private                   1933 (4.73%)                 
                                 Medicaid             468 (3.1%)      109 (0.27%)                  
                                 Medicare             14637 (96.9%)   38370 (93.92%)               
                                 Other                                442 (1.08%)                  
  Comorbidities group, n (%)                                                                      
                                 0                    5551 (36.75%)   7842 (19.2%)                788 (10.26%)
                                 1                    6141 (40.66%)   18479 (45.23%)              2474 (32.21%)
                                 2                    2764 (18.3%)    10838 (26.53%)              2668 (34.73%)
                                 3-10                 649 (4.3%)      3695 (9.04%)                1752 (22.81%)
  Comorbidities details, n (%)                                                                    
  1                              Anemia               2080 (13.77%)   8018 (19.63%)               2683 (34.93%)
  2                              Bleeding disorder    222 (1.47%)     927 (2.27%)                 283 (3.68%)
  3                              COPD                 955 (6.32%)     3402 (8.33%)                448 (5.83%)
  4                              Diabetes             2480 (16.42%)   9169 (22.44%)               1564 (20.36%)
  5                              Hypertension         7356 (48.7%)    26824 (65.66%)              6026 (78.44%)
  6                              Morbid obesity       118 (0.78%)     454 (1.11%)                 125 (1.63%)
  7                              Obesity              301 (1.99%)     2057 (5.04%)                2114 (27.52%)
  8                              Smoking              179 (1.19%)     1059 (2.59%)                280 (3.64%)
                                 Any one of above     9554 (63.25%)   33012 (80.8%)               6894 (89.74%)
  Sum of above                                                                                    
                                 Mean (SD)            0.9 (0.9)       1.3 (0.9)                   1.8 (1)
                                 Median (IQR)         1 (0, 1)        1 (1, 2)                    2 (1, 2)
                                 Range (min-max)      0-5             0-6                         0-6
  ------------------------------ -------------------- --------------- --------------------------- -----------------------------------------------

The primary diagnoses and procedures performed across the databases are presented in Tables [3](#TAB3){ref-type="table"}, [4](#TAB4){ref-type="table"}. The most common diagnosis was spinal stenosis in MarketScan (54.4%), NIS (54.6%), and NSQIP databases (65.2%). Fusion was the most common procedure performed in MarketScan (48.9%) and NIS databases (46.2%), whereas decompression (laminectomy/laminotomy) was the most common procedure in NSQIP database (51.84%). Discectomy for spinal stenosis was the least common procedure performed across the databases. 

###### Primary Diagnoses and Procedures of Cohorts

  ------------------- ---------------------------------------- --------------- --------------------------- -----------------------------------------------
                                                               MarketScan      National Inpatient Sample   National Surgical Quality Improvement Program
  Variable            N=15105                                  N=40854         N=7682                      
  Diagnosis, n (%)                                                                                         
                      Spinal stenosis                          8216 (54.39%)   22328 (54.65%)              5011 (65.23%)
                      Disc herniation                          2474 (16.38%)   6967 (17.05%)               970 (12.63%)
                      Disc protrusion                          2355 (15.59%)   6207 (15.19%)               763 (9.93%)
                      Degeneration                             2060 (13.64%)   5352 (13.1%)                938 (12.21%)
  Procedures, n (%)                                                                                        
                      Fusion                                   7386 (48.9%)    18863 (46.17%)              2185 (28.44%)
                      Decompression (Laminectomy/laminotomy)   6067 (40.17%)   15670 (38.36%)              3982 (51.84%)
                      Discectomy                               1652 (10.94%)   6321 (15.47%)               1515 (19.72%)
  ------------------- ---------------------------------------- --------------- --------------------------- -----------------------------------------------

###### Diagnosis, Procedures, and Complications

  ---------------------------------- ----------------------------- -------------------------- --------------------------- ----------------------------------------------- ---------- ---------------- --------------- ---------------- ---------- -------------- --------------- ---------------- ---------
                                                                   MarketScan                 National Inpatient Sample   National Surgical Quality Improvement Program                                                                                                                           
                                                                   Fusion                     Decompression               Discectomy                                      p-value    Fusion           Decompression   Discectomy       p-value    Fusion         Decompression   Discectomy       p-value
                                                                   n=7386                     n=6067                      n=1652                                          n=18863    n=15670          n=6321                                                                                      
  Diagnosis, n (%)                                                                                                                                                                                                                                                                                
                                     Spinal stenosis               3171 (42.93%)              4742 (78.16%)               303 (18.34%)                                               8249 (43.73%)    12880 (82.2%)   1199 (18.97%)               1136(51.99%)   3120 (78.35%)   755 (49.83%)      
                                     Disc herniation               760 (10.29%)               527 (8.69%)                 1187 (71.85%)                                              1929 (10.23%)    634 (4.05%)     4404(69.67%)                163 (7.46%)    285 (7.16%)     522 (34.46%)      
                                     Disc protrusion               1672 (22.64%)              548 (9.03%)                 135 (8.17%)                                                4195 (22.24%)    1458 (9.3%)     554 (8.76%)                 390(17.85%)    270 (6.78%)     103 (6.8%)        
                                     Degeneration                  1783 (24.14%)              250 (4.12%)                 27 (1.63%)                                                 4490 (23.8%)     698 (4.45%)     164 (2.59%)                 496 (22.7%)    307 (7.71%)     135 (8.91%)       
  In Hospital Complications, n (%)                                                                                                                                                                                                                                                                
  1                                  Acute Kidney Injury           207 (2.8%)                 108 (1.78%)                 36 (2.18%)                                      0.0004     685 (3.63%)      332 (2.12%)     150 (2.37%)      \<0.0001   4 (0.18%)      4 (0.1%)        2 (0.13%)        0.6903
  2                                  Any surgical site infection   29 (0.39%)                 13 (0.21%)                  4 (0.24%)                                       0.155      35 (0.19%)       26 (0.17%)      12 (0.19%)       0.8882     8 (0.37%)      2 (0.05%)       3 (0.2%)         0.0148
  3                                  Cardiac Arrest                17 (0.23%)                 14 (0.23%)                  2 (0.12%)                                       0.6679     48 (0.25%)       26 (0.17%)      5 (0.08%)        0.014      6 (0.27%)      2 (0.05%)       1 (0.07%)        0.0389
  4                                  Deep vein thrombosis          64 (0.87%)                 39 (0.64%)                  12 (0.73%)                                      0.327      127 (0.67%)      77 (0.49%)      33 (0.52%)       0.069      12 (0.55%)     17 (0.43%)      4 (0.26%)        0.4269
  5                                  Myocardial Infarction         64 (0.87%)                 38 (0.63%)                  11 (0.67%)                                      0.252      164 (0.87%)      86 (0.55%)      31 (0.49%)       0.0002     15 (0.69%)     13 (0.33%)      2 (0.13%)        0.0188
  6                                  Pneumonia                     170 (2.3%)                 72 (1.19%)                  14 (0.85%)                                      \<0.0001   307 (1.63%)      161 (1.03%)     58 (0.92%)       \<0.0001   32 (1.46%)     16 (0.4%)       4 (0.26%)        
  7                                  Pulmonary Embolism            46 (0.62%)                 14 (0.23%)                  5 (0.3%)                                        0.0018     68 (0.36%)       42 (0.27%)      8 (0.13%)        0.0092     8 (0.37%)      9 (0.23%)       1 (0.07%)        0.1762
  8                                  Stroke                        67 (0.91%)                 48 (0.79%)                  6 (0.36%)                                       0.0805     89 (0.47%)       48 (0.31%)      21 (0.33%)       0.0357     6 (0.27%)      3 (0.08%)       2 (0.13%)        0.1399
  9                                  Wound Dehiscence              9 (0.12%)                  3 (0.05%)                   0 (0%)                                          0.1593     17 (0.09%)       13 (0.08%)      2 (0.03%)        0.3432     1 (0.05%)      2 (0.05%)                        0.6892
                                     Any one of the above          602 (8.15%)                309 (5.09%)                 78 (4.72%)                                      \<0.0001   1295 (6.87%)     684 (4.37%)     280 (4.43%)      \<0.0001   76 (3.48%)     61 (1.53%)      18 (1.19%)       
  30-day Complications, n (%)                                                                                                                                                                                                                                                                     
  1                                  Acute Kidney Injury           311 (4.21%)                160 (2.64%)                 53 (3.21%)                                      \<0.0001                                                                6 (0.27%)      14 (0.35%)      7 (0.46%)        0.6384
  2                                  Any surgical site infection   201 (2.72%)                119 (1.96%)                 25 (1.51%)                                      0.0011                                                                  48 (2.2%)      54 (1.36%)      19 (1.25%)       0.0214
  3                                  Cardiac Arrest                30 (0.41%)                 15 (0.25%)                  5 (0.3%)                                        0.2731                                                                  7 (0.32%)      7 (0.18%)       3 (0.2%)         0.5011
  4                                  Deep vein thrombosis          181 (2.45%)                104 (1.71%)                 32 (1.94%)                                      0.011                                                                   29 (1.33%)     41 (1.03%)      12 (0.79%)       0.2811
  5                                  Myocardial Infarction         98 (1.33%)                 61 (1.01%)                  16 (0.97%)                                      0.1662                                                                  20 (0.92%)     21 (0.53%)      7 (0.46%)        0.1209
  6                                  Pneumonia                     328 (4.44%)                161 (2.65%)                 44 (2.66%)                                      \<0.0001                                                                49 (2.24%)     36 (0.9%)       8 (0.53%)        
  7                                  Pulmonary Embolism            105 (1.42%)                44 (0.73%)                  19 (1.15%)                                      0.0006                                                                  15 (0.69%)     19 (0.48%)      6 (0.4%)         0.4148
  8                                  Stroke                        119 (1.61%)                88 (1.45%)                  16 (0.97%)                                      0.1437                                                                  10 (0.46%)     8 (0.2%)        4 (0.26%)        0.193
  9                                  Wound Dehiscence              54 (0.73%)                 33 (0.54%)                  6 (0.36%)                                       0.1466                                                                  5 (0.23%)      3 (0.08%)       3 (0.2%)         0.2565
                                     Any one of the above          1125 (15.23%)              630 (10.38%)                174 (10.53%)                                    \<0.0001                                                                159 (7.28%)    172 (4.32%)     59 (3.89%)       
  ---------------------------------- ----------------------------- -------------------------- --------------------------- ----------------------------------------------- ---------- ---------------- --------------- ---------------- ---------- -------------- --------------- ---------------- ---------

Length of hospital stay, complications, and mortality 

The median length of hospital stay was similar across the cohorts (3 days) with IQR of 2-4 days in MarketScan, 2-5 days in NIS, and 1-4 days in NSQIP database. In-hospital complications (any) were 6.5% in the MarketScan cohort, 5.5% in the NIS cohort, and 2% in the NSQIP cohort, with the most common being acute renal injury followed by pneumonia in both MarketScan and NIS database. Whereas pneumonia followed by deep vein thrombosis (DVT) were common complications in NSQIP database. In terms of 30-day complications (any), MarketScan database reported higher complications rate (12.7%) compared to NSQIP database (5.08%) and pneumonia (3.53%) was the most common complication in MarketScan database, whereas surgical site infection (1.58%) was the most common in NSQIP database. In-hospital mortality was slightly higher in the NIS database (0.32%) compared to MarketScan (0.21%) and NSQIP database (0.2%), Table [5](#TAB5){ref-type="table"}.

###### Length of Stay, In-hospital Mortality and Complications

  ---------------------------------- ----------------------------- --------------- --------------------------- -----------------------------------------------
                                                                   MarketScan      National Inpatient Sample   National Surgical Quality Improvement Program
  Variable                           N=15105                       N=40854         N=7682                      
  Length of stay, days                                                                                         
                                     Mean (SD)                     3.6 (3.5)       3.8 (3.5)                   3.5 (3.9)
                                     Median (IQR)                  3 (2, 4)        3 (2, 5)                    3 (1, 4)
                                     Range (min-max)               1-102           0-84                        0-67
  In-hospital mortality, n (%)                                                                                 
                                     Mortality, yes                32 (0.21%)      132 (0.32%)                 15 (0.2%)
  In Hospital Complications, n (%)                                                                             
  1                                  Acute Kidney Injury           351 (2.32%)     1167 (2.86%)                10 (0.13%)
  2                                  Any surgical site infection   46 (0.3%)       73 (0.18%)                  13 (0.17%)
  3                                  Cardiac Arrest                33 (0.22%)      79 (0.19%)                  9 (0.12%)
  4                                  Deep vein thrombosis          115 (0.76%)     237 (0.58%)                 33 (0.43%)
  5                                  Myocardial Infarction         113 (0.75%)     281 (0.69%)                 30 (0.39%)
  6                                  Pneumonia                     256 (1.69%)     526 (1.29%)                 52 (0.68%)
  7                                  Pulmonary Embolism            65 (0.43%)      118 (0.29%)                 18 (0.23%)
  8                                  Stroke                        121 (0.8%)      158 (0.39%)                 11 (0.14%)
  9                                  Wound Dehiscence              12 (0.08%)      32 (0.08%)                  3 (0.04%)
                                     Any one of the above          989 (6.55%)     2259 (5.53%)                155 (2.02%)
  30-day Complications, n (%)                                                                                  
  1                                  Acute Kidney Injury           524 (3.47%)                                 27 (0.35%)
  2                                  Any surgical site infection   345 (2.28%)                                 121 (1.58%)
  3                                  Cardiac Arrest                50 (0.33%)                                  17 (0.22%)
  4                                  Deep vein thrombosis          317 (2.1%)                                  82 (1.07%)
  5                                  Myocardial Infarction         175 (1.16%)                                 48 (0.62%)
  6                                  Pneumonia                     533 (3.53%)                                 93 (1.21%)
  7                                  Pulmonary Embolism            168 (1.11%)                                 40 (0.52%)
  8                                  Stroke                        223 (1.48%)                                 22 (0.29%)
  9                                  Wound Dehiscence              93 (0.62%)                                  11 (0.14%)
                                     Any one of the above          1929 (12.77%)                               390 (5.08%)
  ---------------------------------- ----------------------------- --------------- --------------------------- -----------------------------------------------

Both MarketScan and NIS databases showed an increased risk of complication with increasing age, whereas NIS and NSQIP databases showed increased complications with an increasing number of comorbidities. Male gender had higher complication during index hospitalization using MarketScan and NIS database, and 30-day post-discharge using MarketScan and NSQIP database. Using the MarketScan database, patients with 2 and 3+ comorbidities had 1.21 (1.06, 1.39), and 1.47 (1.18, 1.83) higher odds of experiencing a complication compared to those with no comorbidities, respectively at 30 days after hospitalization. In terms of diagnosis, patients with disc protrusion had a higher risk of complications during index hospitalization and 30 days post-discharge compared to those with a diagnosis of spinal stenosis. Compared to fusion, patients undergoing decompression and discectomy had lower odds of developing complications during index hospitalization \[MarketScan database: Decompression: 0.58 (0.5-0.68); Discectomy: 0.61 (0.47-0.81)\] and \[NIS database: Decompression: 0.6 (0.55-0.67); Discectomy: 0.69 (0.59- 0.8) discectomy\] and 30 days post-discharge, Table [5](#TAB5){ref-type="table"}. 

Discussion
==========

Incorporation of national databases into research has substantially increased in the past few years \[[@REF2],[@REF3],[@REF6],[@REF13],[@REF14]\]. Although these large sample sizes offer researchers opportunities to investigate rare diseases, the statistically significant results are nevertheless susceptible to type I errors, or false-positive results \[[@REF1]\]. Therefore, it is essential to understand the observational and retrospective nature of the database and its sample populations prior to generalizing its outcomes to the total population when given statistically significant results. To our knowledge, this study is the first to compare outcomes and demographics of elderly patients undergoing spine surgery in three commonly used databases.

Demographics and outcomes

In comparing MarketScan, NIS, and NSQIP databases, our study found several differences between the cohorts. Compared to the NIS and NSQIP cohort, the MarketScan cohort was healthier, possibly owing to a larger group of participants with fewer documented comorbidities. Although nearly half the patients' primary procedure was decompression in all three databases, a slightly larger proportion of the MarketScan cohort underwent fusion compared to the NIS and NSQIP cohort. The outcomes of the database reflect the cohort composition. The mortality rates between the sampled populations were not significantly different, which could be due to the overall low mortality rates of spine surgery. In addition, higher rates of complications have been associated with patients undergoing fusion surgery, especially in the elderly, and with those affected by a higher number of comorbidities \[[@REF15]-[@REF20]\]. This could explain why fusion surgery was performed more frequently in the healthier MarketScan population, compared to the sicker NIS population with a higher number of comorbidities. 

Differences in the national administrative databases

Non-uniform methodology of these databases can uncover difficulties in generalizing results and thus drawing clinical significance. Crucial differences can arise from each database's sampling methods. Truven Health Analytics MarketScan® database compiles its samples from claims of employees, Medicare-eligible retirees, early retired, Consolidated Omnibus Budget Reconciliation Act (COBRA) participants and their dependents enrolled through large US corporations in the private sector \[[@REF9],[@REF21]\]. In contrast, HCUP NIS collects a stratified systematic sample from all HCUP hospitals, which is equivalent to 20% of all discharges from community hospitals in the United States \[[@REF10],[@REF14]\]. Based on the method used to collect the cohort sample, NIS is most likely representative of national means and the US population. However, NIS contains information related to hospital discharges only. MarketScan readily offers outpatient visit information, allowing for better understanding in longitudinal aspects for investigation. Since MarketScan collates participants from those insured by large US corporations, their sample may be limited to specific geographic or socioeconomic groups \[[@REF21]\]. It can be argued that because MarketScan databases cover participants who were insured through large US corporations, they may not be as representative or comparable of the general US population. Whereas, NSQIP is a nationally validated program forwarded by the American College of Surgeons (ACS) aimed to improve the quality of surgical care by providing tools to participating hospitals. 

Overall, while it is not surprising to report that advanced aged participants are predominantly enrolled in Medicare, discerning discrepant trends allows patients to choose clinically and economically sound providers to anticipate healthcare costs. An arsenal of comprehensive variables is necessary to streamline patients' experiences and outcomes \[[@REF22]\]. Due to its limited collation of participant data from only US corporations, MarketScan is theoretically unable to present a cohort that is characteristic of the whole US population. Nonetheless, studies examining the quality of NIS data found discrepancies when comparing results derived from patient charts and administrative data from ICD-9 billing codes \[[@REF1],[@REF2],[@REF23]\]. Furthermore, billing-codes are variable on the interpretation and accuracy of the operator (trained vs. naïve) as well as external political and economic pressures leading to variability in application of different codes for a similar procedure in different databases \[[@REF1]\]. 

Since these databases have numerous overlapping variables, and no single database contains all variables, multiple database approach may help compensate for their respective weaknesses. Buckland et al. showed that national databases such as NIS and NSQIP did not capture a similar patient population when compared to physician managed database (PMD) in patients underusing surgery for adult spinal deformity \[[@REF24]\]. This difference can be attributed to the referral pattern and selection bias in the PMD cohort. Similarly, Bohl et al. showed that NIS and NSQIP databases gave different results (complications and comorbidities) in patients with hip fractures \[[@REF25]\]. In concordance to these studies, we found that 30-day post-discharge complications varied significantly between MarketScan (12.77%) and NSQIP database (5.1%). 

According to comorbidity scores alone, NIS and NSQIP patients were less healthy than their MarketScan counterparts. In our study, we used Elixhauser comorbidity index for analysis in all three databases. Nonetheless, it is integral to question the comorbidity indices implemented for the analysis, as not all comorbidities are weighted equally among each index. The algorithm of Elixhauser comorbidity index was developed to predict the inpatient outcomes in hospitalized patients based on their acute and chronic conditions \[[@REF11],[@REF26]\]. It has been demonstrated to predict the in-hospital mortality with respect to disease burden, especially after 30-days of hospitalization \[[@REF27]\]. In contrast, the Charlson comorbidity index was designed to predict one-year mortality based on a patient's comorbidities \[[@REF28]\]. While both calculations are commonly utilized to discriminate for future mortality outcomes, Menendez et al. reported that the Elixhauser comorbidity method outperformed Charlson Index in regards to predicting inpatient outcomes after specifically orthopedic surgery \[[@REF29]\]. Thus, inclusion and exclusion criteria for pertinent variables of candidate databases should be deliberated to identify the optimal database fitting study aims.

Differences yet similarity among databases 

It is important, however, to note that despite vastly different sample sizes, demographics, and collection methods, the primary and secondary results from the databases are not different. The large cohort sizes provide a means to obtain statistical significance that highlight minor differences, but these differences may not be clinically relevant. Additionally, not infrequently, clinicians afford too much attention to p-values, forgetting to vet the generalizability. Although minor differences are highlighted due to the power of the study, broadly, the results of these databases are moderately consistent with one another, suggesting precise results despite differing acquisition methods. Nonetheless, we caution clinicians from generalizing results of database studies. Although they theoretically should represent the population of the country through their sampling methods, generalizing this data to the total population may not be accurate due to the retrospective and observational nature of database studies, especially considering changing practices and advancing minimally invasive technologies. While the owners of the database may promise internal validity, we must be wary of assigning external validity to the total patient population.

Limitations and strengths 

This study has several limitations. First, the accuracy of our results depends largely on the accuracy and consistency of the reported diagnosis and procedure codes. Secondly, the inability to match patients between these three databases limits our capability to reason several of the discovered outcome-discrepancies. Specific patient profiles would allow analysis regarding adherence to evidence-based medicine and hospital guidelines, especially in standards with the geographical location \[[@REF30]\]. One such finding includes the differences in stratified post-operative complications between the three databases. Although the most common specific complications were alike in the three databases, it is difficult to ascertain the discrepancies without additional granular clinical details. 

Notably, MarketScan and NSQIP can track patient data after the perioperative period. In contrast, NIS was limited to information accumulated during the immediate inpatient stay, thereby disallowing longitudinal comparison to determine superiority in that regard. Moreover, because both NIS and MarketScan were not designed to collect spine- or orthopedic-specific data, this study was limited to available variables. Reported improvements in the quality of life and activities of daily living following procedures would provide integral insight into necessary changes required to expand care delivery outcomes. As all databases offer different groups of patient characteristics and widely differ in their sample collection, we remain cognizant of the limitation in the generalizability of the comparison of results and databases.

Conclusions
===========

Even though the results of the three commonly used databases were not completely different, suggesting some consistency despite differing sampling methods, this study captures the discrepancies in the demographics of spine surgery. The disparities drive the variations observed in preoperative comorbid status and inpatient and long-term adverse events. Overall, it appears that the patients in the NSQIP and NIS database have more comorbidities, patients in the MarketScan database had the highest number of perioperative and 30-day post-discharge complications with the highest number of fusion procedures performed. Patients in the NSQIP database had the lowest number of fusion procedures and complication rates. Thus, researchers should be wary of generalizing results from sample populations onto total populations with retrospective, observational database study designs. Future studies may additionally benefit from different database approaches to supplement any vulnerabilities of the primary database.
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###### Summary of ICD-9/10 Primary Complication and Comorbidity Codes Utilized to Query Data from MarketScan, National Inpatient Sample and National Surgical Quality Improvement Program Databases

International Classification of Diseases character 1 (i.e. E, J, N) refers to medical or surgical category designation and character 2 refers to body system. 

  -------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Comorbidities                          International Classification of Diseases-9 Code                                                                                                           International Classification of Diseases-10 Code
  Congestive Heart Failure               39891\',\'40201\',\'40211\',\'40291\',\'40401\',\'40403\',\'40411\',\'40413\',\'40491\', \'40493\',\'4254\',\'4255\',\'4257\',\'4258\',\'4259\',\'428\'   I099\',\'I110\',\'I130\',\'I132\',\'I255\',\'I420\',\'I425\',\'I426\',\'I427\',\'I428\', \'I429\',\'I43\',\'I50\',\'P290\'
  Hypertension                           401\', \'402\',\'403\',\'404\',\'405\'                                                                                                                    I10\', \'I11\',\'I12\',\'I13\',\'I15\'
  Chronic Pulmonary Disease              4168\',\'4169\',\'490\',\'491\',\'492\',\'493\',\'494\',\'495\',\'496\',\'500\',\'501\',\'502\', \'503\',\'504\',\'505\',\'5064\',\'5081\',\'5088\'       I278\',\'I279\',\'J40\',\'J41\',\'J42\',\'J43\',\'J44\',\'J45\',\'J46\',\'J47\',\'J60\',\'J61\', \'J62\',\'J63\',\'J64\',\'J65\',\'J66\',\'J67\',\'J684\',\'J701\',\'J703\'
  Diabetes                               2500\',\'2501\',\'2502\',\'2503\', \'2504\',\'2505\',\'2506\',\'2507\',\'2508\',\'2509\'                                                                  E100\',\'E101\',\'E109\',\'E110\',\'E111\',\'E119\',\'E120\',\'E121\',\'E129\',\'E130\', \'E131\',\'E139\',\'E140\',\'E141\',\'E149\', \'E102\',\'E103\',\'E104\',\'E105\',\'E106\',\'E107\',\'E108\',\'E112\',\'E113\',\'E114\',\'E115\', \'E116\',\'E117\',\'E118\',\'E122\',\'E123\',\'E124\',\'E125\',\'E126\',\'E127\',\'E128\',\'E132\',                           \'E133\',\'E134\',\'E135\',\'E136\',\'E137\',\'E138\',\'E142\',\'E143\',\'E144\',\'E145\',\'E146\', \'E147\',\'E148\'
  Renal Failure                          40301\',\'40311\',\'40391\',\'40402\',\'40403\',\'40412\',\'40413\',\'40492\',\'40493\', \'585\',\'586\',\'5880\',\'V420\',\'V451\',\'V56\'               I120\',\'I131\',\'N18\',\'N19\',\'N250\',\'Z490\',\'Z491\',\'Z492\',\'Z940\',\'Z992\'
  Metastatic Cancer                      196\',\'197\',\'198\',\'199\'                                                                                                                             C77\',\'C78\',\'C79\',\'C80\'
  Coagulopathy                           286\',\'2871\',\'2873\',\'2874\',\'2875\'                                                                                                                 D65\',\'D66\',\'D67\',\'D68\',\'D691\',\'D693\',\'D694\',\'D695\',\'D696\'
  Obesity                                2780\'                                                                                                                                                    E66\'
  Weight Loss                            260\',\'261\',\'262\',\'263\',\'7832\',\'7994\'                                                                                                           E40\',\'E41\',\'E42\',\'E43\',\'E44\',\'E45\',\'E46\',\'R634\',\'R64\'
  Fluid and Electrolyte Disorders        2536\',\'276\'                                                                                                                                            E222\',\'E86\',\'E87\'
  Complications                                                                                                                                                                                     
  Renal                                  584.xx; 997.5                                                                                                                                             N17.x; N99.89
  Cardiac                                410.xx; 997.1                                                                                                                                             I21.x; I97.7xx; I97.8xx
  Nervous system Complication            997.09                                                                                                                                                    G978.x
  Stroke/CVA with neurological deficit   434.01; 434.11; 434.91                                                                                                                                    I63.3x; I63.4x; I63.5x; 
  DVT and pulmonary embolism             415.xx; 451.xx; 452; 453.xx                                                                                                                               I26.xx; I80.xx; I81.xx; I82.xx
  Pulmonary                              518.4; 518.5; 518.8x; 997.3x                                                                                                                              J81.0; J80; J95.1; J95.2; J95.3; J95.8xx; J96.xx
  Infection                              595.0; 595.9; 599.0                                                                                                                                       N30.00; N30.01; N30.90; N30.91; N39.0
  Wound                                  998.32; 998.51; 998.6; 998.81; 998.83                                                                                                                     T81.31xx; T81.4xx; T81.8xxx
  Pneumonia                              481.xx; 482.xx; 486.xx                                                                                                                                    J13-J18.x
  -------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Summary of ICD-9/10 Primary Procedure Codes Utilized to Query Data from MarketScan, National Inpatient Sample and National Surgical Quality Improvement Program Databases

International Classification of Diseases character 1 (i.e. E, J, N) refers to medical or surgical category designation and character 2 refers to body system, character 3 (i.e. 0B, 0G) refers to root operation. 

  ----------------- -------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------------
  Procedures        International Classification of Diseases-9 Code                      International Classification of Diseases-10 Code                                                                              Current Procedural Terminology Code           Description for International Classification of Diseases-9
  Decompression                                                                                                                                                                                                                                                       
                    03.09 (this includes all levels)                                     0RBxyZZ(X=0,1,4,6,A); 0SBxyZZ(X=0,3); -Excision                                                                               22102, 22114, 22207,22214, 22224              Other exploration and decompression of spinal canal
                                                                                         00NxyZZ(x=W, X,Y), -Release                                                                                                   63005, 63012, 63017,63030, 63035,              
                                                                                         009xy0Z, 009xyZZ(x=T, W, X,Y); 009U00Z, 009U0ZZ-Drainage                                                                                                                     
                                                                                         00JV0ZZ, 00JU0ZZ -Inspection                                                                                                  63042, 63047, 63056,63087, 63090,              
                    80.50 -Excision or destruction of intervertebral disc, unspecified                                                                                                                                 63102, 0171T, 0202T, 0221T, 63200,            Excision or destruction of intervertebral disc, unspecified
                                                                                                                                                                                                                       63252, 63267, 63272,63277, 63282,              
                    80.51 -Excision of intervertebral disc                               0RBxyZZ(X=3,5,9,B); 0SBxyZZ(X=2,4); -Excision                                                                                 63387, 63302,63303, 63306, 63307,             Excision of intervertebral disc
                                                                                         0RTx0ZZ(X=3,4,5,9,B); 0STx0ZZ(X=2,4); -Resection                                                                                                                             
                    80.59 -Other destruction of intervertebral disc                      0R5x0ZZ(X=3,5,9,B); 0S5xyZZ(X=2,4); -Destruction  (+ icd10 for 80.51)                                                                                                       Other destruction of intervertebral disc
                    84.6x -disc replacement                                              0RRx0JZ(x=3,5,9,B); 0SRx0JZ(x=2,4); 0RWxyJZ(x=3,5,9,B); 0SWxyJZ(x=2,4);                                                                                                      
                                                                                         0RPx0JZ+0RRx0JZ(x=3,5,9,B); 0SPx0JZ+0SRx0JZ(x=2,4)                                                                                                                           
  Exclude           81.65                                                                0PU33JZ, 0PU34JZ, 0PU43JZ, 0PU44JZ, 0QU03JZ, 0QU04JZ, 0QU13JZ, 0QU14JZ                                                                                                      Percutaneous vertebroplasty
  Exclude           81.66                                                                0PS33ZZ+0PU33JZ ;0PS43ZZ+0PU43JZ; 0QS03ZZ+0QU03JZ; 0QS13ZZ+0QU13JZ; 0QSS3ZZ+0QUS3JZ                                                                                         Percutaneous vertebral augmentation
  Fusion                                                                                                                                                                                                                                                              
  Cervical fusion   81.01                                                                0RG0xyz(y=7,J, K,Z,A; z=0,1,J) total=45                                                                                       22548,22551,22554,22595,22590, 22600          Atlas-axis spinal fusion
                    81.02                                                                0RGsxy0(s=1,2,4; y=7,J,K,Z,A)  total=45                                                                                                                                     Other cervical fusion of the anterior column, anterior technique
                    81.03                                                                0RGsxy1(s=1,2,4; y=7,J,K,Z,A) total=45                                                                                                                                      Other cervical fusion of the posterior column, posterior technique
                                                                                         0RGsxyJ(s=1,2,4; y=7,J,K,Z,A) total=45-Posterior Approach, Anterior Column                                                                                                  Cervical fusion
  Thoracic fusion   81.04                                                                0RGsxy0(s=4,6,7,8,A; y=7,J,K,Z,A) total=75                                                                                    22532, 22554, 22556,22610                     Dorsal and dorsolumbar fusion of the anterior column, anterior technique  
                    81.05                                                                0RGsxy1(s=4,6,7,8,A; y=7,J,K,Z,A) total=75                                                                                                                                  Dorsal and dorsolumbar fusion of the posterior column, posterior technique
                                                                                         0RGsxyJ(s=4,6,7,8,A; y=7,J,K,Z,A) total=75                                                                                                                                  Thoracic fusion  
  Lumbar fusion     81.06                                                                0SGsxy0(s=0,1,3; y=7,J,K,Z,A) total=45;-Fusion of Lumbar Vertebral Joint, Anterior Approach, Anterior Column, Open Approach   22533,22558,22586, 22612,22630,22633, 0195T   Lumbar and lumbosacral fusion of the anterior column, anterior technique
                                                                                         0RGAxy0(y=7,J,K,Z,A) total=15; -Fusion of Thoracolumbar Vertebral Joint, Anterior Approach, Anterior Column, Open Approach                                                   
                    81.07                                                                0SGsxy1(s=0,1,3; y=7,J,K,Z,A) total=45; -Fusion of Lumbar Vertebral Joint                                                                                                   Lumbar and lumbosacral fusion of the posterior column, posterior technique
                                                                                         0RGAxy1(y=7,J,K,Z,A) total=15 -Fusion of Thoracolumbar Vertebral Joint,Posterior Approach, Posterior Column, Open Approach                                                   
                    81.08                                                                0SGsxyJ(s=0,1,3; y=7,J,K,Z,A) total=45;-Fusion of Lumbar Vertebral Joint                                                                                                    Lumbar and lumbosacral fusion of the anterior column, posterior technique
                                                                                         0RGAxyJ(y=7,J,K,Z,A) total=15; -Fusion of Thoracolumbar Vertebral Joint, Posterior Approach, Anterior Column                                                                Lumbar fusion
  ----------------- -------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------------

###### Summary of ICD-9/10 Primary Diagnosis Codes Utilized to Query Data from MarketScan, National Inpatient Sample and National Surgical Quality Improvement Program Databases

International Classification of Diseases character 1 (i.e. E, J, N) refers to medical or surgical category designation and character 2 refers to body system, character 3 (i.e. 0B, 0G) refers to root operation. 

  ------------------------- ------------------------------------------------- -------------------------------------------------- -----------------------------------------------------------------
  Diagnosis                 International Classification of Diseases-9 Code   International Classification of Diseases-10 Code   International Classification of Diseases-9 Description
  Spinal stenosis           723.0                                             M48.01, M48.02, M48.03, M99.21-M99.71              Spinal stenosis in cervical region
                            724.00                                            M48.00,                                            Spinal stenosis, unspecified region
                            724.01                                            M48.04, M48.05, M99.22-M99.72                      Spinal stenosis, thoracic region
                            724.02                                            M48.06, M48.07, M99.23- M99.73                     Spinal stenosis, lumbar region, without neurogenic claudication
                            724.03 -claudication                                                                                 Spinal stenosis, lumbar region, with neurogenic claudication
                            724.09                                            M48.08, M99.24-M99.74                              Spinal stenosis, other region
  Disk herniation           722.0                                             M50.2x                                             Displacement of cervical intervertebral disc without myelopathy
                            722.10                                            M51.26, M51.27                                     Displacement of lumbar intervertebral disc without myelopathy
                            722.11                                            M51.24, M51.25                                     Displacement of thoracic intervertebral disc without myelopathy
  Disc protrusion           722.30                                                                                               Schmorl's nodes, unspecified region
                            722.31                                            M51.44, M51.45                                     Schmorl's nodes, thoracic region
                            722.32                                            M51.46, M51.47                                     Schmorl's nodes, lumbar region
                            722.4                                             M50.3x                                             Degeneration of cervical intervertebral disc
                            722.51                                            M51.34, M51.35                                     Degeneration of thoracic or thoracolumbar intervertebral disc
                            722.52                                            M51.36, M51.37                                     Degeneration of lumbar or lumbosacral intervertebral disc
                            722.71                                            M50.0x                                             Intervertebral disc disorder with myelopathy, cervical region
                            722.72                                            M51.04, M51.05                                     Intervertebral disc disorder with myelopathy, thoracic region
                            722.73                                            M51.06, M51.07                                     Intervertebral disc disorder with myelopathy, lumbar region
  Degenerative conditions   724.1                                             M54.6                                              Pain in thoracic spine
                            724.3                                             M54.3x                                             Sciatica
                            724.4                                             M54.14- M54.17                                     Thoracic or lumbosacral neuritis or radiculitis, unspecified
                            724.5                                             M54.89, M54.9                                      Backache, unspecified
                            724.9                                             M43.8x9, M53.80, M53.84, M53.85, M53.9             Other unspecified back disorders
                            738.4                                             M43.0x, M43.1x                                     Acquired spondylolisthesis
                            756.11                                            Q76.2                                              Spondylosis, lumbosacral region
                            756.12                                            Q76.2                                              Spondylolisthesis
                            756.19                                            Q76.41x, Q76.49                                    Other anomalies of spine
  ------------------------- ------------------------------------------------- -------------------------------------------------- -----------------------------------------------------------------
